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Abstract
Background:  Systemic infection with HIV occurs infrequently through the oral route. The
frequency of occurrence may be increased by concomitant bacterial infection of the oral tissues,
since co-infection and inflammation of some cell types increases HIV-1 replication. A putative
periodontal pathogen, Porphyromonas gingivalis selectively up-regulates expression of the HIV-1
coreceptor CCR5 on oral keratinocytes. We, therefore, hypothesized that P. gingivalis modulates
the outcome of HIV infection in oral epithelial cells.
Results: Oral and tonsil epithelial cells were pre-incubated with P. gingivalis, and inoculated with
either an X4- or R5-type HIV-1. Between 6 and 48 hours post-inoculation, P. gingivalis selectively
increased the infectivity of R5-tropic HIV-1 from oral and tonsil keratinocytes; infectivity of X4-
tropic HIV-1 remained unchanged. Oral keratinocytes appeared to harbor infectious HIV-1, with
no evidence of productive infection. HIV-1 was harbored at highest levels during the first 6 hours
after HIV exposure and decreased to barely detectable levels at 48 hours. HIV did not appear to
co-localize with P. gingivalis, which increased selective R5-tropic HIV-1 trans  infection from
keratinocytes to permissive cells. When CCR5 was selectively blocked, HIV-1 trans infection was
reduced.
Conclusion: P. gingivalis up-regulation of CCR5 increases trans infection of harbored R5-tropic
HIV-1 from oral keratinocytes to permissive cells. Oral infections such as periodontitis may,
therefore, increase risk for oral infection and dissemination of R5-tropic HIV-1.
Background
Systemic infection after oral exposure to HIV-1 has been
reported in breastfed infants from seropositive mothers
[1]. Whether HIV/AIDS is acquired through oral exposure
to seminal fluid from HIV-positive individuals remains
equivocal [2]. Yet, experimental evidence points to the
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plausibility that exposure of the oral mucosal epithelium
to HIV-1 results in primary infection of the oral tissues fol-
lowed by systemic dissemination. For example, when sim-
ian immunodeficiency virus (SIV) is non-traumatically
swabbed on the gingival and buccal mucosa of primates,
oral epithelial infection is evident within one day [3,4],
while systemic infection occurs within a week [5]. Con-
sistent with these observations, human oral epithelial
cells of HIV-infected patients contain integrated HIV-1
DNA, which may result from either primary infection or
systemic dissemination of the virus [6]. HIV-1 has also
been suggested to infect human oral epithelial cells in
vitro [7,8]. Recent work from our laboratory shows that
replication aborts after viral integration, while harbored
virions are transmissible from oral keratinocytes to per-
missive cells [9]. In vivo, however, human oral epithelium
is generally not considered a target for primary infection
by HIV-1 [10,11].
Mucosal exposure is responsible for the vast majority of
the current HIV infections worldwide [12] and R5-tropic
HIV-1 accounts for most of primary infections [13-15]. In
mucosal tissues such as in the gut, CCR5 has been pro-
posed to act as a "gatekeeper", facilitating primary infec-
tion by R5-tropic while excluding X4-tropic HIV-1
[14,16,17]. Indeed, primary R5-tropic HIV-1 infection
generally requires target cells that carry a specific receptor
for gp120 such as CD4 and the chemokine coreceptor
CCR5 [18]. Interestingly, a homozygous defect in expres-
sion of the R5-tropic coreceptor CCR5 is associated with
resistance to HIV-1 infection in frequently exposed indi-
viduals [9]. On mucosal surfaces where epithelial cells
predominate, the mechanism by which R5-tropic HIV-1 is
specifically selected, and X4 HIV-1 is relatively excluded
remains unclear. Many potential "gatekeeper" mecha-
nisms have been proposed [17]. More than relying on a
single "gatekeeper", selective R5-HIV transmission seems
to depend on the aggregate activity of cell and tissue spe-
cific restrictive barriers and facilitated uptake mechanisms
encountered as HIV-1 passes from the mucosal surface to
permissive cells in the organized lymphoid tissues [17].
Healthy squamous oral keratinocytes predominately
express CXCR4 [7], but low to undetectable levels of
CCR5 [19,20] and there is no expression of the major
HIV-1 receptor, CD4 [7,11,21,22]. Given that oral kerati-
nocytes can integrate HIV-1 DNA, alternative HIV-1 recep-
tors have been proposed, including galactosyl ceramide
(GalCer) [23,24], heparan sulfate proteoglycans [11,25],
syndecans [26,27], and mannose receptor [28,29]. In con-
cert with CXCR4 (X4-tropic HIV-1 specific) or CCR5 (R5-
tropic HIV-1 specific) chemokine coreceptors, these alter-
native receptors have been suggested to take up infectious
HIV-1 [30], which can then be transferred to permissive
cells [27,30-32].
Since oral epithelial cells express only CXCR4
[7,19,20,22], and oral keratinocytes in vitro can internal-
ize and transfer infectious HIV-1 [22], we sought to learn
if CCR5 coreceptor regulation by co-infecting oral bacteria
could result in increased uptake and transfer of R5-tropic
HIV-1. Co-infecting viruses, such as human herpesvirus 6
(HHV-6) and HHV-7, down-regulate expression of the
HIV-1 co-receptor, CXCR4 [33,34]. Since HHV modula-
tion does not affect CCR5, CXCR4 down-regulation may
increase the relative expression of CCR5, enhancing the
"gatekeeper". Our group has recently shown that Porphy-
romonas gingivalis, an endogenous periodontal pathogen,
selectively up-regulates CCR5 in oral keratinocytes [20].
These cells increase CCR5 expression when signaled
through protease-activated receptors (PAR) and TLRs by
the P. gingivalis putative virulence factors, gingipains (Rgp
and Kgp) and LPS, respectively [20]. We, therefore,
hypothesized that P. gingivalis co-infection increases HIV-
1 transfer of infectious R5-tropic HIV-1 from oral kerati-
nocytes to permissive cells. In the absence of productive
infection in oral keratinocytes, we showed that P. gingiva-
lis caused a CCR5-dependent increase in transfer of R5-
tropic HIV-1. As a consequence of primary non-produc-
tive infection, R5-tropic HIV-1 is suggested to disseminate
selectively from oral mucosal epithelium in association
with P. gingivalis infection in periodontitis.
Results
P. gingivalis-induced release of infectious R5-specific HIV-
1 from oral epithelial cells
To learn whether P. gingivalis might increase release of
infectious HIV-1, TERT-2 cells were pre-incubated with P.
gingivalis, and then inoculated with R5- or X4-tropic HIV-
1. Supernatants were collected and presented to reporter
TZM-bl cells to assay for infectious HIV-1. From 7 to 54 h
post-inoculation, TERT-2 cells pre-incubated with P. gingi-
valis released significantly more infectious R5-tropic HIV-
1 into the supernatants than cells incubated with virus
alone (Fig. 1A). Release of the X4-tropic strain was unaf-
fected by P. gingivalis (Fig. 1B) and was slightly lower than
R5-tropic HIV-1, particularly at 7 and 9 h post-inocula-
tion. Like TERT-2 cells, tonsil epithelial cells released sig-
nificantly more infectious R5-tropic HIV-1 when pre-
incubated with P. gingivalis (Fig. 1C).
Since the R5-tropic HIV-1-containing TERT-2 cell superna-
tants were more infectious when cells were pre-treated
with P. gingivalis, we sought to learn whether TERT-2 cells
released more HIV-1 p24. In the presence or absence of P.
gingivalis, TERT-2 cells released similar amounts of p24
after inoculation with R5- (Fig. 2A) or X4-HIV-1 (Fig. 2B).
From 7 to 18 h post-inoculation, X4- and R5-tropic HIV
p24 released from TERT-2 cells increased and then
remained constant until 54 h.Retrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
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Effect of P. gingivalis on TERT-2 cell-associated HIV-1
To determine if P. gingivalis increased viral association
with TERT-2 cells, RNA from infected TERT-2 cells was
recovered between 7 and 54 hours post-inoculation and
HIVgag RNA was quantified by real-time PCR. In the pres-
ence and absence of P. gingivalis, greater levels of HIVgag
RNA were generally recovered from R5- (Fig. 2C) than X4-
HIV-1 (Fig. 2D) infected TERT-2 cells.
P. gingivalis effects on HIV-1 replication
To determine if P. gingivalis affects HIV-1 replication in the
oral keratinocytes, TERT-2 cells were pre-incubated with
the bacterium and inoculated with either HIV-1 strain.
RNA was extracted from the TERT-2 cells and singly
spliced HIV-1vpr transcripts (newly synthesized mRNA)
were quantified by real-time PCR. In the presence or
absence of P. gingivalis, singly spliced Ba-L and IIIb tran-
scripts were undetectable in the oral keratinocytes for up
to 54 h post-inoculation (data not shown). When TZM-bl
cells were inoculated directly, however, singly spliced Ba-
L and IIIb transcripts increased about 100-fold between 7
and 54 h post-inoculation (Fig. 3). After inoculation with
HIV-1 IIIB or Ba-L, TZM-bl cells, but not TERT-2 cells, con-
tained p24gag as shown by immunoblotting (data not
shown). These data suggest that there is no replicative
cycle of HIV-1 in TERT-2 cells, even when cells are pre-
incubated with P. gingivalis.
P. gingivalis increases harbored infectious HIV-1 in TERT-
2 cells
Since  P. gingivalis pre-incubation caused a selective
increase in release of infectious R5-HIV-1 from TERT-2
cells (Fig. 1A), we determined whether infectious virions
were internalized or plasma membrane-associated. Oral
keratinocytes were pre-incubated with P. gingivalis and
inoculated with HIV-1 as previously. At times from 7 to 54
h post-inoculation, cultures were washed to remove
loosely associated virus and adherent, plasma membrane-
associated HIV was detached using trypsin for 5 min. To
assess the infectious levels of the detached viral particles,
Assay of infectious HIV-1 virions released by oral epithelial cells Figure 1
Assay of infectious HIV-1 virions released by oral epithelial cells. TERT-2 cells (A and B) and primary tonsil cells (C), 
with and without P. gingivalis pre-incubation, were incubated with (A and C) R5-HIV-1 (Ba-L) or (B) X4-HIV-1 (IIIb) as 
described in the Materials and Methods. In brief, cell monolayers were incubated with P. gingivalis for 3 h, washed, inoculated 
with HIV-1 and incubated for 3 h, washed and then incubation continued for the total elapsed time as shown. At the indicated 
times, culture supernatants were harvested from the infected TERT-2 or tonsil epithelial cells and incubated with TZM-bl 
reporter cells for 2 h. At 2 h, the TZM-bl medium was changed and incubation continued for 24 h. Cells were stained with X-
Gal and infected reporter cells per well were counted. Data represent the mean number ± SEM of infected reporter TZM-bl 
cells per well at the times indicated from 4 independent experiments. * p-value < 0.05, ** p-value < 0.001.
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the medium was recovered and the trypsin was inacti-
vated. The infectivity of the recovered HIV-1 was assayed
using the TZM-bl reporter cells. Based on the responses of
TZM-bl reporter cells, more infectious plasma membrane-
associated R5-tropic HIV-1 was detached from TERT-2
cells pre-incubated with P. gingivalis than in the absence at
all times (Fig. 4A). In the presence and absence of P. gin-
givalis, similar amounts of infectious membrane-associ-
ated X4-tropic HIV-1 were detached from TERT-2 cells
(Fig. 4B). After removing the plasma membrane-associ-
ated virions, cells were lysed to recover internalized HIV-
1. Lysates were inoculated onto the reporter TZM-bl cells
to assess the levels of infectious intracellular HIV-1 within
the oral keratinocytes. Oral epithelial cells pre-incubated
with P. gingivalis contained more infectious intracellular
R5-tropic HIV-1 than P. gingivalis-untreated cells (Fig. 4C).
X4-HIV-1 inoculated keratinocytes contained barely
detectable levels of intracellular infectious virus, which
was unaffected by P. gingivalis (Fig. 4D). Hence, P. gingiva-
lis increases harbored membrane-associated and intracel-
lular R5-tropic HIV-1.
Increase in TERT-2 cell-associated infectious R5-tropic 
HIV-1 blocked by anti-CCR5 antibodies
To explain increased cell-associated, infectious R5-tropic
HIV-1 fractions (plasma membrane and intracellular), we
first considered the possibility that R5-tropic HIV-1 binds
P. gingivalis, which subsequently invades the oral kerati-
nocytes [35]. TERT-2 cells were pre-incubated with P. gin-
givalis, inoculated with R5-HIV-1 and observed by
confocal microscopy. P. gingivalis and HIV-1 were also co-
incubated on glass slides without cells and then observed.
P. gingivalis and viruses did not appear to co-localize when
co-cultured in the absence (Fig. 5A) or presence (Fig. 5B
and 5C) of oral keratinocytes. When pre-incubated with P.
gingivalis, TERT-2 cells appeared to contain more intracel-
lular HIV-1 (data not shown).
Total HIV-1 load associated with oral epithelial cells Figure 2
Total HIV-1 load associated with oral epithelial cells. (A and B) TERT-2 cells were pre-incubated with and without P. 
gingivalis and then inoculated with R5- (A) and X4-HIV-1 (B). Harvested at the indicated times, supernatants were analyzed for 
HIV p24 by ELISA. The protocol is as described in the Materials and Methods and summarized in the legend of Fig. 1. Values are 
the mean of 3 independent experiments and are expressed as ng/mL of p24 ± SEM. (C and D) Expression of HIVgag in TERT-2 
cells. TERT-2 and TZM-bl cells were pre-incubated with or without P. gingivalis and then inoculated with HIV-1 Ba-L (C) or IIIb 
(D). Total RNA was extracted from the cells, reverse transcribed and used as template in real-time PCR for HIVgag RNA. HIV-
gag RNA in TERT-2 cells was expressed relative to the expression in TZM-bl cells at 7 h after HIV inoculation. Beta actin was 
used as housekeeping gene. Data represent the mean of 3 independent experiments ± SEM.
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We next tested whether up-regulation of the CCR5 HIV-1
coreceptor on TERT-2 cells [20] by P. gingivalis could con-
tribute to the infectivity of R5-tropic HIV-1. Oral keratino-
cytes were pre-incubated with P. gingivalis, then incubated
with anti-CCR5 antibody, and inoculated with HIV Ba-L.
At 18 h post-inoculation, spent culture supernatants and
TERT-2 cell lysates were recovered and assayed for infec-
tivity using TZM-bl reporter cells. Anti-CCR5 caused a
dose-dependent reduction in infectious R5-tropic HIV-1
from both the culture supernatants and the intracellular
compartment of TERT-2 cells (Fig. 5D). At the highest
dose tested, anti-CCR5 blocked the increase in R5-tropic
HIV-1 infectivity attributable to P. gingivalis (Fig. 5D).
P. gingivalis increases cell-to-cell trans infection of 
intracellular infectious HIV-1 from oral keratinocytes
Since  P. gingivalis-pre-incubated cells contained more
intracellular infectious R5-HIV-1 than unexposed kerati-
nocytes (Fig. 4C), we studied whether P. gingivalis
increased HIV entry to the cells. TERT-2 cells were exposed
to P. gingivalis and both strains of HIV-1 as described pre-
viously. Plasma membrane-associated HIV-1 was
removed by trypsin and TERT-2 cells were lysed at various
times. Consistent with the ELISA data from the culture
supernatants (Fig. 2A and 2B), TERT-2 cells pre-incubated
in the presence or absence of P. gingivalis contained simi-
lar intracellular p24gag after inoculation with either R5-
(Fig. 6A) or X4-tropic HIV-1 (Fig. 6B). When comparing
both viral strains, however, levels of p24gag were higher for
R5- than X4-tropic HIV-1 (Fig. 6A, B), which was consist-
ent with the data for cell-associated HIVgag RNA (Fig. 2C
and 2D) and supernatant p24gag (Fig. 2A and 2B).
We next sought to learn whether oral keratinocytes pre-
incubated with P. gingivalis transferred more infectious
intracellular R5-HIV to permissive cells in co-culture. After
trypsinization and removal of extracellular virus, P. gingi-
valis pre-incubated TERT-2 cells were incubated with R5-
HIV-1 or X4-HIV-1 for 6 h and cultured for 18 h post-inoc-
ulation. At 18 h, infected TERT-2 cells were harvested and
co-cultured with TZM-bl reporter cells for an additional
24 h. TERT-2 cells trans infected TZM-bl cells with more
infectious R5-tropic HIV-1 when pre-incubated in the
presence of P. gingivalis than in the absence (Fig. 6C). In
contrast, X4-HIV-1 trans infection from TERT-2 cells to
TZM-bl cells was not affected by P. gingivalis and was
lower than R5-HIV-1 (data not shown).
To determine whether trans infection of intracellular R5-
HIV-1 was CCR5-dependent, TERT-2 cells pre-incubated
with P. gingivalis were incubated with anti-CCR5 antibody
and then inoculated with R5- or X4-HIV-1. TERT-2 cells
incubated with CCR5 antibody and R5- or X4-HIV-1, in
the absence of P. gingivalis served as negative control.
Blocking the TERT-2 cell CCR5 receptor with antibodies
significantly reduced trans  infection of R5-HIV-1 (p <
0.001) (Fig. 6C) but not X4-HIV-1 (not shown) to TZM-bl
cells. After pre-incubation with P. gingivalis, anti-CCR5
reduced trans infection of R5-tropic HIV-1 to levels similar
to HIV-1 inoculated TERT-2 cells without P. gingivalis.
To confirm the role of CCR5, TERT-2 cells with or without
pre-incubation with P. gingivalis were incubated with the
CCR5 ligand, RANTES, at 30 and 300 ng/mL or with 10 or
100 nM of TAK-779. TAK-779 selectively blocks HIV
gp120 interaction with CCR5 [36]. Consistent with the
CCR5 antibody data, cells incubated with RANTES (Fig.
6D) or TAK-799 (data not shown) before inoculation with
HIV-1 showed statistically significant (p < 0.05) dose-
dependent reductions in the increased transfer of R5-HIV-
1 mediated by P. gingivalis. As expected, TERT-2 cells inoc-
ulated with X4 viruses in the presence or absence of P. gin-
givalis were not affected by RANTES or TAK-779 (data not
shown). In the absence of HIV-1, TERT-2 cells incubated
with either P. gingivalis, CCR5 antibody, RANTES or TAK-
779, showed no false-positive transfer (staining by TZM-
bl reporter) (data not shown).
At harvest, co-cultured TERT-2 cells, which had been
washed and trypsinized to remove extracellular and
HIV-1 replication undetectable in oral keratinocytes Figure 3
HIV-1 replication undetectable in oral keratinocytes. 
TZM-bl cells and TERT-2 cells were pre-incubated with and 
without P. gingivalis and then inoculated with R5- or X4-HIV-
1 strains, washed and incubation continued in fresh medium. 
The protocol is as described in the Materials and Methods 
and summarized in the legend of Fig. 1. At the indicated 
times, total RNA was extracted, reverse transcribed, and 
analyzed by real-time PCR for the singly spliced gene HIV-
1vpr. For both cell lines, relative expression of HIV vpr-spe-
cific singly spliced mRNA (fold-change) is presented in com-
parison to the levels in TZM-bl cells at 7 h. Beta actin was 
used as housekeeping gene. Data represent the mean ± SEM 
of 3 independent experiments. Shown only are data points 
for TZM-bl cells + HIV-1 IIIb and BaL and TERT-2 cells + 
HIV-1 BaL. Note that P. gingivalis had no effect on the fold-
change in HIV vpr-specific, singly spliced mRNA.
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plasma membrane-associated HIV-1, appeared to trans
infect the TZM-bl reporter cells (Fig. 6E). In some fields,
blue TZM-bl cells and TERT-2 cells appeared to grow inde-
pendently (Fig. 6E, panel I). More commonly, blue TZM-
bl cells and TERT-2 cells grew in direct contact (panels II,
III). In comparison to co-culture with HIV-1 infected
TERT-2 cells, TZM-bl-to-TZM-bl trans  infection of R5-
tropic HIV-1 resulted in 100-fold more infected reporter
cells (data not shown), increased multinuclear cells with
syncytia formation, and more intense staining (Fig. 6E,
panel IV). Although the contact status with TZM-bl cells at
the time of trans infection was not established, the images
suggest that TERT-2 cells trans infect either released virus
or directly transferred internalized HIV-1 mediated by
cell-to-cell contacts. P. gingivalis-mediated increased trans-
fer of intracellular HIV-1 was unrelated to reverse tran-
scription. Indeed, AZT (500 µM) maintained
continuously in TERT-2 cells cultures did not affect the
increase in R5-tropic HIV-1 trans infection caused by P.
gingivalis (data not shown).
Discussion
Endogenous bacteria may modulate HIV-1 infection. For
example, we have shown that the oral endogenous patho-
gen, P. gingivalis, can up-regulate CCR5 on oral keratinoc-
ytes [20]. We next sought to learn whether CCR5 up-
regulation by P. gingivalis could modulate dissemination
of R5-tropic HIV-1 from oral keratinocytes. In this report,
we show that P. gingivalis increases the transmissibility of
infectious R5-tropic HIV-1 to proximal permissive cells in
vitro without affecting the dissemination of X4-tropic
HIV-1. To the best of our knowledge, this is the first report
of interactions between septic oral epithelial cells and
HIV-1.
HIV-1 infection never occurs in a sterile environment and
the septic mucosal environment may affect susceptibility
to HIV-1 infection. The oral mucosa and virtually all
mucosal epithelial tissues are colonized by polymicrobial
biofilms that may modify the acquisition of HIV-1 infec-
tion. Co-infecting microorganisms that affect the clinical
P. gingivalis increases infectious HIV-1 associated with oral keratinocyte plasma membrane and intracellular fractions Figure 4
P. gingivalis increases infectious HIV-1 associated with oral keratinocyte plasma membrane and intracellular 
fractions. TERT-2 cells with or without pre-incubation with P. gingivalis were inoculated with R5- (Ba-L) (A and C) or X4-
tropic (IIIb) (B and D) HIV-1. The protocol is as described in the Materials and Methods and summarized in the legend of Fig. 1. 
After washing, cells were trypsinized to recover membrane-associated (A and B) and cell-associated, trypsin-resistant infec-
tious HIV-1 (C and D). To assay for infectious HIV-1 virions, virus-containing fractions were incubated with TZM-bl cells, 
stained with X-Gal and positive blue cells counted as described in the Materials and Methods. Data represent the mean ± SEM 
of TZM-bl positive cells from two independent experiments, each in triplicate.
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course of HIV-AIDS or mechanisms of infection include
Mycobacterium tuberculosis [37], human hepatitis C virus
[38], hepatitis B (HBV) [39] herpes simplex virus-2 (HSV-
2) [40], Neisseria gonorrhea [41], cytomegalovirus,
Epstein-Barr virus, HHV-6, -7, and -8, and human papil-
loma virus [42]. When HIV and Leishmania co-infect, the
severity increases for both infections [43]. Similarly, the
malaria-causing protozoan Plasmodium is highly associ-
ated with the occurrence [44] and severity of HIV infec-
tions [45]. Co-infection with Mycobacterium avium may
directly increase the severity of infection by increasing
HIV-1 replication [46].
P. gingivalis is a putative pathogen associated with perio-
dontitis, a polymicrobial infection of the gingiva and
tooth-supporting connective tissues, bone and ligament
[47]. When challenged with commensal and pathogenic
bacteria, oral keratinocytes release cytokines and chemok-
ines [48], which may function as chemoattractants for
CD4-positive T cells [49]. Infiltrating CD4+ T cells can
then co-localize with keratinocytes, facilitating docking
Increase in TERT-2 cell-associated, infectious HIV-1 independent of direct interactions with P. gingivalis and blocked by anti- CCR5 Figure 5
Increase in TERT-2 cell-associated, infectious HIV-1 independent of direct interactions with P. gingivalis and 
blocked by anti-CCR5. (A) P. gingivalis was co-cultured with R5-HIV-1 on glass slides. (B and C) TERT-2 cells were pre-incu-
bated with P. gingivalis, washed and inoculated with R5-HIV (Ba-L), washed, fixed and permeabilized for confocal microscopy 
analysis. Cells were stained with antibodies (1:100 dilutions) against P. gingivalis and HIV p24, or isotype control IgG. The con-
focal analysis was validated for assessment of intracellular HIV-1 using TZM-bl cells. Color key: Blue, DAPI; Red, Alexa 568; and 
Green, FITC conjugated IgG. Scale bars: 5 µm (A), 10 µm (B and C). Pictures are representative of 2 independent experiments 
and show one z-slice through the middle of the nucleus. (D), TERT-2 cells were pre-incubated with P. gingivalis or untreated 
and then incubated with anti-CCR5 antibody for 1 h. All TERT-2 cell cultures were then inoculated with R5-HIV-1. Culture 
supernatants (gray) and cell lysates (black) were collected at 18 hours post-inoculation with P. gingivalis as described in the leg-
end of Fig. 1. Infectious virions were estimated using TZM-bl reporter cells. Data represent the mean ± SEM of 3 independent 
experiments, each performed in triplicate.
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and transfer of infectious virions [49]. In the gingiva,
immature dendritic (Langerhans) cells [50] typically co-
localize with keratinocytes and T cells [51]. Indeed, we
show that TERT-2 cells contact and apparently transfer
virus to co-cultured CD4-positive TZM-bl cells (Fig. 6E
panels II–III), whereas the virus does not appear to inter-
act directly with P. gingivalis (Fig. 5). The data also show
that virus released by TERT-2 cells can also be captured by
TZM-bl cells (Fig. 6E panel I). TZM-bl cells were used to
both assay infectivity of cell-free HIV-1 and serve as a per-
missive target for trans infection of HIV-1 from oral kerat-
inocytes. The results in TZM-bl cells parallel data we have
obtained using primary tonsil keratinocytes and several
keratinocyte cell lines using peripheral blood mononu-
clear cells as permissive targets (Vacharaksa et al, unpub-
lished data).
In the presence of P. gingivalis, TERT-2 (Fig. 6C, D) and
primary tonsil epithelial cells (data not shown) selectively
increase trans infection of R5-tropic HIV-1 to TZM-bl cells.
The selective increase in infectious R5-tropic HIV-1 on the
plasma membranes and within TERT-2 cells (Fig. 4), and
CCR5-dependent cell-to-cell transfer of infectious HIV-1 Figure 6
CCR5-dependent cell-to-cell transfer of infectious HIV-1. TERT-2 cells were pre-incubated with P. gingivalis or 
untreated and then inoculated with (A) R5- and (B) X4-HIV-1. The protocol is as described in the Materials and Methods and 
summarized in the legend of Fig. 1. Cells were trypsinized, washed, and lysed. The lysates were assayed for HIV p24 by ELISA. 
Similarly, TERT-2 cells were pre-incubated with P. gingivalis or untreated and then incubated with (C) a 1:10 dilution of 200 µg/
mL anti-CCR5 antibody or (D) with 30 ng/mL or 300 ng/mL of the CCR5 inhibitor RANTES, and R5-HIV-1 for 6 h (in the pres-
ence of the antibody or RANTES). At 18 h post-inoculation, oral keratinocytes were detached with trypsin, washed twice and 
seeded onto TZM-bl cells for co-culture. Data represent the mean ± SEM from 3 independent experiments, each performed in 
triplicate. * p-value < 0.05, ** p-value < 0.001. (E) Photomicrographs of X-gal stained cell co-cultures of TERT-2 cells pre-incu-
bated with P. gingivalis and infected with Ba-L for 6 h (I, II and III) as described above. In the co-cultures with TZM-bl cells, 
arrows identify some proximal TERT-2 cells (panels II and III). Positive control Ba-L-inoculated TZM-bl cells co-cultured with 
TZM-bl cells are also shown (IV). In panel IV, the arrow shows a multinucleated TZM-bl cell.
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release into the extracellular environment (Fig. 1A) is
independent of new viral replication (Fig. 3). TERT-2 cells
appear to take up and contain the same amount of HIV-1
over time in the presence and absence of P. gingivalis
based on HIV-1gag RNA and p24 levels (Fig. 2). The rea-
son for this striking increase in infectivity is not clear. The
amount of recovered virus protein or RNA can be discord-
ant with levels of infectious virions [26,52]. Furthermore,
non-permissive HIV-1 infection of oral keratinocytes
occurs at low frequency, and small differences in the pres-
ence and absence of P. gingivalis may challenge the sensi-
tivity and discrimination of the detection assays. To
estimate viral infectivity, we show that counting 10 to 40
positive cells of the 1 × 104 TZM-bl cells per well is repro-
ducible and reliable. Infectivity apparently discriminates
better than detection or quantification of viral protein. It
is clear, however, that the ability of keratinocytes to bind
and capture HIV-1, as estimated by HIVgag RNA and p24
levels, does not reflect the persistence and transfer of
infectious virions to target cells.
Two plausible mechanisms emerge to explain the P. gingi-
valis-mediated selective increase in infectious R5-tropic
HIV-1. As a consequence of P. gingivalis, TERT-2 cells selec-
tively harbor and protect infectious R5-tropic HIV-1, but
not CXCR4-tropic virus. In addition, trans infection of R5-
tropic HIV-1 to permissive TZM-bl cells also increases in a
CCR5 up-regulation-dependent manner. Although both
are dependent on pre-incubation with P. gingivalis, these
mechanisms differ.
In response to P. gingivalis, infectious virions were consist-
ently recovered from TERT-2 cell culture medium (Fig.
1A), cell surface (Fig. 4A) and within the cell (Fig. 4C).
AZT treatment did not affect viral infectivity suggesting
that transfer of intracellular R5-HIV-1 from oral keratino-
cytes was independent of intracellular viral uncoating or
reverse transcription. Harbored HIV-1 remains infectious
for up to two days (Figs. 1A, 4A, C). Dendritic cells show
similar capability. For example, attachment of HIV-1 to
DC-SIGN preserves infectious virus up to 4 days [53].
When compared to cells that do not express DC-SIGN,
preservation of viral infectivity results in an increase in
trans infection to CD4+ permissive cells [53]. The P. gingi-
valis-mediated selective increase in cell-associated R5-
tropic HIV-1 suggests a novel protective activity is
expressed in oral epithelial cells. This protective activity
for harbored HIV-1 may be independent of the expression
of CCR5. Protective activity may function directly on R5-
tropic virus or by inhibiting HIV-1 inactivation mecha-
nisms. P. gingivalis alters the gene expression profile in
TERT-2 cells through lipopolysaccharide activation of
Toll-like receptors and protease activation of protease-
activated receptors [20]. Therefore, modulation of innate
immunity by P. gingivalis may enable keratinocytes to
increase the infectivity of harbored R5-tropic HIV-1.
Perhaps in concert with protection of harbored virus, we
also showed that P. gingivalis-mediated upregulation of
CCR5 in TERT-2 cells [20] increases the effectiveness of
trans infection to permissive TZM-bl cells (CD4+ CXCR4+
CCR5+). In TERT-2 cells, CCR5 appears to function pri-
marily in trans, increasing the delivery of R5-tropic HIV-1
to CD4+ permissive cells. The trans function appears to be
analogous to DC-SIGN on dendritic cells, which enables
trans  infection to permissive cells [53]. Clearly, CCR5
blockade with specific antibodies, RANTES or a receptor
antagonist inhibits the P. gingivalis-mediated increase in
selective R5-tropic HIV-1 trans infection (Figs. 5, 6). The
CCR5-dependent increase in trans infection of R5-tropic
HIV-1 could reflect TERT-2 cell uptake, release or cell-to-
cell transfer of virus. That P. gingivalis does not affect levels
or kinetics of intracellular HIV-1gag RNA (Fig. 2C, D) and
p24 (Fig. 6A, B) argues against a significant role for CCR5
in selective R5-tropic HIV-1 uptake in these cells. While
the data suggest strongly that CCR5 is necessary for the
specific trans infection of R5-tropic HIV-1, it is likely that
internalization of the virus within the keratinocyte is
CCR5-independent. Consistent with our findings, block-
ing CCR5 antibodies reduced transcytosis of R5-specific
HIV-1 through primary genital epithelial cells, resulting in
attenuated infection of CD4+ cells [27]. Furthermore, up-
regulation of CCR5 appears to be necessary, but may not
be sufficient for trans infection. The net effect of the P. gin-
givalis-mediated up-regulation of CCR5 expression, how-
ever, appears to be an increase in the proportion of R5-
tropic HIV-1 that successfully transits though the kerati-
nocyte to trans infect permissive targets.
Interestingly,  P. gingivalis proteases, particularly RgpA,
inhibit gp120-mediated HIV-1 fusion with the highly per-
missive MT4 T-cell line and facilitate proteolysis of the
CD4 receptor [54]. In the present study, the CD4-negative
oral keratinocytes [7,11,21,22] show HIV internalization
in the presence of P. gingivalis Rgp. Like dendritic cells
(DCs) [12], HIV-1 appears to enter CD4- cells by endocy-
tosis, involving clathrin-coated vesicles [55,56] or mac-
ropinosomes [57]. Like DCs [53,58], infection of oral
keratinocytes is non-productive (Vacharaksa et al, unpub-
lished), but it remains to be learned whether, like DCs
[12,59], keratinocytes use synapse formation to trans
infect. Indeed, recent evidence suggests that HIV-1 enters
oral keratinocytes by an endocytic pathway within min-
utes (Dietrich et al, unpublished) without apparent reli-
ance on gp120 and CD4-mediated membrane fusion
[56,57]. If P. gingivalis modifies interactions between
receptors or co-receptors and HIV-1, candidate targets
would be other than cell-fusion associated CD4, CXCR4
and CCR5. Clearly, the interactions between TERT-2 cellsRetrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
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and P. gingivalis are complex and up-regulation of CCR5
provides only a partial explanation for the increase in
trans infection of R5-tropic HIV-1. If these mechanisms
simulate pathways in vivo, the oral keratinocyte would be
placed in the circuit of transmission of HIV-1, capturing
R5-tropic HIV-1 from the mucosal surface and transferring
the infectious virus to permissive cells such as infiltrating
CD4-positive T cells or specific intraepithelial dendritic
cells (DCs). Since iDCs dock with CD4+ T cells, P. gingiva-
lis-infected oral keratinocytes can contribute to the selec-
tive systemic dissemination of R5-tropic HIV-1.
Collectively, these data suggest that select mucosal sites in
the oral cavity such as the periodontal tissues, where
organisms like P. gingivalis are often abundant in the com-
plex microflora [60], may contribute to the complex set of
restrictions and enabling pathways that in aggregate serve
as the mucosal gatekeeper system for primary R5-tropic
HIV-1 clinical infection [17]. A CCR5-dependent gate-
keeper mechanism, or one that is regulated by an endog-
enous co-pathogen, P. gingivalis, has not been previously
recognized in oral epithelia. Somewhat analogous to P.
gingivalis  in oral keratinocytes [20], the oral pathogen
Actinobacillus actinomycetemcomitans increases expression
of HIV-1 coreceptors in monocytes [61]. Under condi-
tions of inflammation or infection, polarized human
endometrial cells also increase release of infectious HIV-1
to the extracellular compartment [32]. Furthermore, in
periodontitis, the epithelial barrier is disrupted [46],
increasing the proximity of virus or virus-infected kerati-
nocytes to target T-cells [32,62], release of pro-inflamma-
tory cytokines [63] and activation of TLR-dependent
signaling pathways by bacteria [64]. Inflammation in the
gingiva and oral mucosa could enhance HIV-1 infection
of the oral tissues. For example, certain bacterial patho-
gens [64] and E. coli LPS [65] increase HIV-1 promoter
activity by signaling through TLR4. We find no evidence
that P. gingivalis increase HIV-1 transcriptional activity in
TERT-2 cells. In control experiments, we ruled out that P.
gingivalis and its products in spent bacterial media could
activate the LTR promoter in TZM-bl cells (data not
shown). Since infectious HIV-1 can be harbored in oral
keratinocytes, the squamous mucosal epithelium may
also constitute a cryptic reservoir of infection in vivo,
which is enhanced specifically for R5-tropic HIV-1 in the
presence of P. gingivalis. Periodontal disease and other
oral infections and inflammatory conditions may, there-
fore, affect the risk for systemic dissemination of HIV-1
from an oral focus. If this speculation is confirmed, novel
therapeutic strategies could be developed to thwart HIV-1
at its point of entry.
Methods
Cells
Immortalized human oral keratinocytes OKF6/TERT-2
(TERT-2) [66] were provided by James Rheinwald of Har-
vard Medical School and cultured essentially as described
previously [22]. In brief, cells were grown in 5% CO2 at
37°C in keratinocyte serum-free (KSF-M; Gibco), supple-
mented with 0.3 mM CaCl2, 25 µg/mL bovine pituitary
extract and 0.2 ng/mL epidermal growth factor (TERT-2
medium). Culture media was changed every two days and
cells were subcultured at 60 to 70% confluency (about 5
days). Using an IRB approved protocol, palatine tonsil tis-
sues were obtained from routine tonsillectomies per-
formed at the Hennepin County Medical Center,
Minneapolis, MN. Primary tonsil epithelial cells were iso-
lated and cultured using a protocol modified from Oda
and Watson [67] as described [67]. In brief, tonsil cells
were cultured and the medium was partially replaced
(70%) every 2 days. Once the primary culture was estab-
lished, cells were passaged after 4 days in culture at 70 to
80% confluence. Only cells growing in passage 3 or 4 were
used for the experiments. Tonsil epithelial cells were at
least 96% epithelial based on flow cytometric analysis
using epithelial and fibroblast markers. To serve as a pos-
itive control and also as permissive targets for HIV-1 infec-
tion, TZM-bl cells (JC53) [68] were obtained from and
cultured as recommended by the NIH AIDS Research and
Reference Reagent Program, MD.
Viruses and bacteria
The X4- (IIIb) (AIDS Research and Reference Reagent Pro-
gram, Division of AIDS, NIAID, NIH: HTLV-IIIB/H9 from
Dr. Robert Gallo, Cat. 398)[69] and R5-tropic HIV-1 (Ba-
L) (AIDS Research and Reference Reagent Program, Divi-
sion of AIDS, NIAID, NIH: HIV-1Ba-L from Dr. Suzanne
Gartner, Dr. Mikulas Popovic and Dr. Robert Gallo, Cat.
510)[70] strains were propagated in peripheral blood
mononuclear cells (PBMCs) using the protocols of the
NIH AIDS Research and Reference Reagent Program. To
estimate the amount of infectious virus, the 50% infection
endpoint method (TCID50) of Reed-Muench was used
[71,72]. TCID50 of virus stocks was determined in PHA-
activated PBMCs. A multiplicity of HIV-1 infection (MOI)
of 0.005 was used to infect the cells (TCID50 per cell).
P. gingivalis, strain ATCC 33277, was grown under anaer-
obic conditions in a Coy anaerobic chamber (85% N2, 5%
CO2 and 10% H2) at 37°C on Todd-Hewitt agar plates
(Difco) supplemented with 5% (v/v) defibrinated sheep
blood or in Todd-Hewitt broth supplemented with 5 µg/
mL hemin (Sigma) and 1 µg/mL menadione (Sigma).
Bacteria were grown in 5 mL of broth for approximately
72 h to an OD620 nm of 0.9 to 1.1 (early stationary phase)
and counted for determination of the bacterial MOI by
the spiral plate method [73].Retrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
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Infections with P. gingivalis and HIV-1
To serve as targets of HIV-1 infection, TERT-2 or tonsil epi-
thelial cells (1 × 105) were seeded in 24-well plates and
grown overnight. Culture medium was removed, replaced
with fresh pre-warmed medium and freshly harvested P.
gingivalis were added at a MOI of 100 for 3 h at 37°C in
spent Todd-Hewitt broth to a final volume of 500 µL.
After P. gingivalis incubation, cells were washed 5 times
with Dulbecco's Phosphate-Buffered Saline (DPBS)
(Gibco). Negative control cells (unexposed to P. gingiva-
lis) were incubated with anaerobic Todd-Hewitt broth,
and grown under identical conditions. After removing the
bacteria at 3 h, HIV-1 IIIb or Ba-L in 500 µL of medium
was inoculated at an MOI 0.005 onto keratinocyte cul-
tures and incubated. At 6 h, cells were washed 5 times
with DPBS to remove excess virus, fresh medium was
added, and incubation continued for up to 54 h post-
inoculation with P. gingivalis (48 h after washing to
remove HIV-1). At each time point, three different sam-
ples were obtained: (i) released HIV-1 in 500 µL of spent
cell culture supernatants; (ii) plasma membrane-associ-
ated HIV-1, and (iii) intracellular, trypsin-resistant HIV-1.
To recover plasma membrane-associated virus (sample
ii), cells were treated with 250 µL of 0.05% trypsin-EDTA
(Gibco) for 5 min at 37°C. Trypsin was inactivated by
addition of equal volumes of DMEM (Mediatech) supple-
mented with 10% FBS (TZM-bl medium). Cell suspen-
sions were collected, centrifuged at 5,255 × g for 1 min
and supernatants were recovered containing membrane-
associated HIV that was released by trypsin. The resulting
cell pellet containing intracellular HIV-1 (sample iii) was
resuspended in 500 µL of TZM-bl medium, lysed by 3
cycles of freezing under liquid N2 and thawing at room
temperature. Lysis was verified by light microscopy. The
three samples were stored at -20°C for infectious virion
assay (see below) or p24 ELISA. HIV p24 in cell samples
was estimated by ELISA (Beckman-Coulter) as described
by the manufacturer.
TZM-bl reporter assay for infectious HIV
To determine transfer of infectious HIV-1 from oral kerat-
inocytes, TZM-bl cells were seeded at 1 × 104 cells per well
and grown overnight in 96-well plates. The HIV-1 samples
(100 µL of a 1:2 dilution) were incubated with TZM-bl
reporter cells for 2 h at 37°C in 5% CO2, washed 3 times
with TZM-bl medium, and incubated for 24 h. TZM-bl
cells were then fixed with 100 µL of 0.05% glutaraldehyde
for 5 min, and washed 3 times with DPBS. Cells were then
covered with 50 µL of X-Gal solution (500 mM potassium
ferrocyanide, 500 mM potassium ferricyanide, 0.1 M mag-
nesium chloride and 20 mg/mL X-Gal; all from Sigma)
and incubated for 2 h at 37°C in 5% CO2. After staining,
blue positive cells were counted in each well under a light
microscope. To assess specificity of the reporter cell to HIV
infection, monolayers of TZM-bl cells were exposed to P.
gingivalis-exposed and unexposed TERT-2 or TZM-bl
supernatants without HIV-1 (negative control). At most, 1
or 2 blue-stained cells per well were detected as a false
positive result.
Co-culture of infected TERT-2 cells with reporter TZM-bl 
cells
TERT-2 cells were pre-incubated with P. gingivalis for 3 h,
washed 5 times, incubated with R5-HIV-1 (Ba-L) for 6 h,
washed 5 times and incubated in TERT medium for 18 h
post-inoculation. Extracellular HIV-1 was then removed
by trypsin, cells were washed twice with TZM-bl medium
and resuspended in TERT medium. TERT-2 cells (1 × 104)
in suspension were added to monolayers of TZM-bl
reporter cells per well in a mixture of equal volumes of
TERT and TZM-bl media. Co-cultures were maintained for
24 h at 37°C in 5% CO2 and stained with X-Gal solution,
as above.
Quantitative PCR
Total RNA was extracted from oral keratinocytes with an
AllPrep RNA/DNA Kit (Qiagen) according to the manu-
facturer's instructions and quantitated using the 2100 Bio-
analizer (Agilent Technologies). Total RNA (500 ng) was
used as template to make cDNA using the Superscript III
First Strand Synthesis System for RT-PCR (Invitrogen).
The cDNA was then diluted 1:5 with RNase/DNase free
water and 1 µl (5 ng) was used as template in the Plati-
num SYBR Green qPCR SuperMix-UDG w/ROX (Invitro-
gen). Quantitative PCR was performed on each sample in
triplicate on an ABI7900 HT (Applied Biosystems) and
subsequent analysis of the data was obtained using SDS
2.1 software (Applied Biosystems), normalizing all genes
to human beta-actin (SuperArray Bioscience), employing
the delta-delta CT method of relative quantitation [74].
To characterize the HIV-1 life cycle, singly spliced HIV-
1vpr transcripts and HIVgag RNA primers were used as
shown in Table 1 and also [9].
Confocal microscopy
TERT-2 cells (2 × 105) were seeded on cover slips in 12-
well plates and cultured overnight at 37°C in 5% CO2.
Cells were incubated for 3 h with P. gingivalis ATCC 33277
at MOI 100, washed 5 times with DPBS, inoculated with
HIV Ba-L for 2 h at MOI 0.005 and washed 5 more times.
TERT-2 cells were prepared for microscopic observation,
as described [20]. For some experiments, P. gingivalis and
HIV Ba-L were co-cultured on glass slides without cells.
Cells were incubated with a 1:100 dilution (v/v) of
murine anti-HIV p24 IgG1 monoclonal antibody (Chemi-
con Int., Millipore), murine IgG1 isotype control anti-
body (BD Biosciences, Pharmingen), or rabbit polyclonal
anti-P. gingivalis IgG. After antibody incubation, cells were
washed 5 times and incubated with ALEXA 568-conju-
gated donkey anti-murine IgG antibody (MolecularRetrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
Page 12 of 14
(page number not for citation purposes)
Probes) diluted 1:2000 (v/v) and/or FITC-conjugated goat
anti-rabbit IgG antibody (Sigma) (1:1000 (v/v) dilution)
and DAPI (Molecular Probes) at a 1:3000 (v/v) dilution
for 1 h. Samples were observed using a confocal micro-
scope (Olympus FluoView 1000). From each field, 10 to
30 consecutive sections of 0.5 µm thickness were resolved
at 1024 × 1024 pixels, analyzed and pseudo-colored. Co-
localization of antigens was determined in single sections
from the image stacks. Final images were generated using
ImageJ 1.37V software (National Institutes of Health).
Microscope settings were kept identical for all images cap-
tured.
CCR5 blocking experiments
CCR5 was blocked on TERT-2 cells using goat anti-human
CCR5 polyclonal antibody (CKR-5; Santa Cruz), recom-
binant human RANTES (CCL5) (Peprotech) or TAK-779
(NIH AIDS Research and Reference Reagent Program,
Division of AIDS, NIAID, NIH:TAK-779) [36] essentially
as reported previously [20]. In the presence of anti-human
CCR5 or RANTES, TERT-2 cells were pre-incubated in the
presence or absence of P. gingivalis. Cells were then inocu-
lated with HIV-1 Ba-L or IIIb at a MOI 0.005, incubated
for 6 h, washed 5 times with DPBS and cultured for 18 h
post-inoculation. Culture supernatants or cell lysates were
recovered, stored at -20°C and inoculated onto TZM-bl
cells to report infectious HIV. In some experiments, TERT-
2 cells were trypsinized at 18 h post-inoculation and co-
cultured with TZM-bl cells, as described above. Infectious
virus from the samples was assayed in TZM-bl cells as
described above. Oral keratinocytes in the presence or
absence of P. gingivalis were used as positive and negative
controls, respectively.
Statistical analyses
Statistical analyses were performed by the Student's t test
for paired values using GraphPad software. Differences
were considered significant at a p < 0.05.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
RAG conceived the study and designed the experiments,
carried out most of the experimental work and drafted the
manuscript. ACA performed all the real-time PCR reac-
tions, contributed in the design of the experiments and
actively participated in discussions about the study. KHG
and EAD helped in the development of the infectivity
assays, contributed editorial suggestions to the final ver-
sions of the manuscript and participated in helpful discus-
sions. AV developed some of the protocols for the viral
infections and the culture of the cells used in this study.
KFR helped in the editing of the final versions of the man-
uscript and contributed to the analysis of the data. MCH
advised about the study and its design, critically revised
the manuscript, suggested significant modifications to its
content and gave final approval to the submitted version.
Acknowledgements
These studies were supported by NIH grants-in-aid DE015503 (to MCH), 
DE15506 (KFR), the Veterans Affairs Research Service, and the Mucosal 
and Vaccine Research Center. The expert technical support and advice of 
Claudine Fasching is greatly appreciated. This manuscript was submitted in 
partial fulfillment of the requirements for the PhD degree by RAG.
References
1. Coovadia HM, Rollins NC, Bland RM, Little K, Coutsoudis A, Bennish
ML, Newell ML: Mother-to-child transmission of HIV-1 infec-
tion during exclusive breastfeeding in the first 6 months of
life: an intervention cohort study.  Lancet 2007,
369(9567):1107-1116.
2. Younai FS: Oral HIV transmission.  J Calif Dent Assoc 2001,
29(2):142-148.
3. Milush JM, Kosub D, Marthas M, Schmidt K, Scott F, Wozniakowski
A, Brown C, Westmoreland S, Sodora DL: Rapid dissemination of
SIV following oral inoculation.  Aids 2004, 18(18):2371-2380.
4. Milush JM, Stefano-Cole K, Schmidt K, Durudas A, Pandrea I, Sodora
DL:  Mucosal innate immune response associated with a
timely humoral immune response and slower disease pro-
gression after oral transmission of simian immunodeficiency
virus to rhesus macaques.  J Virol 2007, 81(12):6175-6186.
5. Abel K, Pahar B, Van Rompay KK, Fritts L, Sin C, Schmidt K, Colon
R, McChesney M, Marthas ML: Rapid virus dissemination in
infant macaques after oral simian immunodeficiency virus
Table 1: Primer sequences and PCR conditions
Target Primer Sequences (5'-3') PCR conditions
Gag For CCCATAGTGCAGAACATCCA 50°C, 2 min, 95°C, 2 min, and 95°C, 15 s and 60°C, 30 s, for 
50 cycles
Rev GGGCTGAAAGCCTTCTCTTC
Singly spliced M669 GTGTGCCCGTCTGTTGTGTGACTCTGGTAAC 50°C, 2 min, 95°C, 2 min, and 95°C, 15 s and 60°C, 30 s, for 
50 cycles
La 23 GCCTATTCTGCTATGTCGACACC
β -actin Actin F ATGGCCACGGCTGCTTCCAGC 95°C, 15 s, 55°C, 30 s, 72°C, 15 s for 30 cycles
Actin R CATGGTGGTGCCGCCAGACAG
GAPDH GAPDH F GAGTCAACGGATTTGGTCGT 95°C, 15 s, 60°C, 30 s, 72°C, 15 s for 30 cycles
GAPDH R TTGATTTTGGAGGGATCTCGRetrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
Page 13 of 14
(page number not for citation purposes)
exposure in the presence of local innate immune responses.
J Virol 2006, 80(13):6357-6367.
6. Rodriguez-Inigo E, Jimenez E, Bartolome J, Ortiz-Movilla N, Bar-
tolome Villar B, Jose Arrieta J, Manzarbeitia F, Carreno V: Detection
of human immunodeficiency virus type 1 RNA by in situ
hybridization in oral mucosa epithelial cells from anti-HIV-1
positive patients.  J Med Virol 2005, 77(1):17-22.
7. Liu X, Zha J, Chen H, Nishitani J, Camargo P, Cole SW, Zack JA:
Human immunodeficiency virus type 1 infection and replica-
tion in normal human oral keratinocytes.  J Virol 2003,
77(6):3470-3476.
8. Moore JS, Rahemtulla F, Kent LW, Hall SD, Ikizler MR, Wright PF,
Nguyen HH, Jackson S: Oral epithelial cells are susceptible to
cell-free and cell-associated HIV-1 infection in vitro.  Virology
2003, 313(2):343-353.
9. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDon-
ald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect
in HIV-1 coreceptor accounts for resistance of some multi-
ply-exposed individuals to HIV-1 infection.  Cell 1996,
86(3):367-377.
10. Lu FX, Jacobson RS: Oral mucosal immunity and HIV/SIV infec-
tion.  J Dent Res 2007, 86(3):216-226.
11. Kumar RB, Maher DM, Herzberg MC, Southern PJ: Expression of
HIV receptors, alternate receptors and co-receptors on ton-
sillar epithelium: implications for HIV binding and primary
oral infection.  Virol J 2006, 3:25.
12. Wilkinson J, Cunningham AL: Mucosal transmission of HIV-1:
first stop dendritic cells.  Curr Drug Targets 2006,
7(12):1563-1569.
13. Meng G, Wei X, Wu X, Sellers MT, Decker JM, Moldoveanu Z, Oren-
stein JM, Graham MF, Kappes JC, Mestecky J, Shaw GM, Smith PD:
Primary intestinal epithelial cells selectively transfer R5 HIV-
1 to CCR5+ cells.  Nat Med 2002, 8(2):150-156.
14. Moore JP, Kitchen SG, Pugach P, Zack JA: The CCR5 and CXCR4
coreceptors--central to understanding the transmission and
pathogenesis of human immunodeficiency virus type 1 infec-
tion.  AIDS Res Hum Retroviruses 2004, 20(1):111-126.
15. Reynes J, Portales P, Segondy M, Baillat V, Andre P, Avinens O, Picot
MC, Clot J, Eliaou JF, Corbeau P: CD4 T cell surface CCR5 den-
sity as a host factor in HIV-1 disease progression.  Aids 2001,
15(13):1627-1634.
16. Bomsel M, David V: Mucosal gatekeepers: selecting HIV viruses
for early infection.  Nat Med 2002, 8(2):114-116.
17. Margolis L, Shattock R: Selective transmission of CCR5-utilizing
HIV-1: the 'gatekeeper' problem resolved?  Nat Rev Microbiol
2006, 4(4):312-317.
18. Sullivan N, Sun Y, Sattentau Q, Thali M, Wu D, Denisova G, Gershoni
J, Robinson J, Moore J, Sodroski J: CD4-Induced conformational
changes in the human immunodeficiency virus type 1 gp120
glycoprotein: consequences for virus entry and neutraliza-
tion.  J Virol 1998, 72(6):4694-4703.
19. Cutler CW, Jotwani R: Oral mucosal expression of HIV-1
receptors, co-receptors, and alpha-defensins: tableau of
resistance or susceptibility to HIV infection?  Adv Dent Res
2006, 19(1):49-51.
20. Giacaman RA, Nobbs AH, Ross KF, Herzberg MC: Porphyromonas
gingivalis Selectively Up-Regulates the HIV-1 Coreceptor
CCR5 in Oral Keratinocytes.  J Immunol 2007, 179(4):2542-2550.
21. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber
J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, Medvik K, Sieg SF,
Weinberg A: Human epithelial beta-defensins 2 and 3 inhibit
HIV-1 replication.  Aids 2003, 17(16):F39-48.
22. Vacharaksa A, Asrani A C, Gebhard K, Faschling C, Janoff  E, Ross K
F, Herzberg M C: Infection and Replication of HIV-1 in Immor-
talized Oral Keratinocytes.  Submitted 2007.
23. Kage A, Shoolian E, Rokos K, Ozel M, Nuck R, Reutter W, Kottgen
E, Pauli G: Epithelial uptake and transport of cell-free human
immunodeficiency virus type 1 and gp120-coated micropar-
ticles.  J Virol 1998, 72(5):4231-4236.
24. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez-Scarano F:
Infection of colonic epithelial cell lines by type 1 human
immunodeficiency virus is associated with cell surface
expression of galactosylceramide, a potential alternative
gp120 receptor.  Proc Natl Acad Sci U S A 1993, 90(7):2700-2704.
25. Saidi H, Magri G, Nasreddine N, Requena M, Belec L: R5- and X4-
HIV-1 use differentially the endometrial epithelial cells HEC-
1A to ensure their own spread: implication for mechanisms
of sexual transmission.  Virology 2007, 358(1):55-68.
26. Bobardt MD, Saphire AC, Hung HC, Yu X, Van der Schueren B,
Zhang Z, David G, Gallay PA: Syndecan captures, protects, and
transmits HIV to T lymphocytes.  Immunity 2003, 18(1):27-39.
27. Bobardt MD, Chatterji U, Selvarajah S, Van der Schueren B, David G,
Kahn B, Gallay PA: Cell-free human immunodeficiency virus
type 1 transcytosis through primary genital epithelial cells.  J
Virol 2007, 81(1):395-405.
28. Szolnoky G, Bata-Csorgo Z, Kenderessy AS, Kiss M, Pivarcsi A,
Novak Z, Nagy Newman K, Michel G, Ruzicka T, Marodi L, Dobozy
A, Kemeny L: A mannose-binding receptor is expressed on
human keratinocytes and mediates killing of Candida albi-
cans.  J Invest Dermatol 2001, 117(2):205-213.
29. Liu Y, Liu H, Kim BO, Gattone VH, Li J, Nath A, Blum J, He JJ: CD4-
independent infection of astrocytes by human immunodefi-
ciency virus type 1: requirement for the human mannose
receptor.  J Virol 2004, 78(8):4120-4133.
30. Delezay O, Koch N, Yahi N, Hammache D, Tourres C, Tamalet C,
Fantini J: Co-expression of CXCR4/fusin and galactosylcera-
mide in the human intestinal epithelial cell line HT-29.  Aids
1997, 11(11):1311-1318.
31. Bomsel M: Transcytosis of infectious human immunodefi-
ciency virus across a tight human epithelial cell line barrier.
Nat Med 1997, 3(1):42-47.
32. Carreno MP, Krieff C, Irinopoulou T, Kazatchkine MD, Belec L:
Enhanced transcytosis of R5-tropic human immunodefi-
ciency virus across tight monolayer of polarized human
endometrial cells under pro-inflammatory conditions.
Cytokine 2002, 20(6):289-294.
33. Yasukawa M, Hasegawa A, Sakai I, Ohminami H, Arai J, Kaneko S,
Yakushijin Y, Maeyama K, Nakashima H, Arakaki R, Fujita S: Down-
regulation of CXCR4 by human herpesvirus 6 (HHV-6) and
HHV-7.  J Immunol 1999, 162(9):5417-5422.
34. Secchiero P, Zella D, Barabitskaja O, Reitz MS, Capitani S, Gallo RC,
Zauli G: Progressive and persistent downregulation of surface
CXCR4 in CD4(+) T cells infected with human herpesvirus 7.
Blood 1998, 92(12):4521-4528.
35. Nisapakultorn K, Ross KF, Herzberg MC: Calprotectin expression
in vitro by oral epithelial cells confers resistance to infection
by Porphyromonas gingivalis.  Infect Immun 2001,
69(7):4242-4247.
36. Baba M, Nishimura O, Kanzaki N, Okamoto M, Sawada H, Iizawa Y,
Shiraishi M, Aramaki Y, Okonogi K, Ogawa Y, Meguro K, Fujino M: A
small-molecule, nonpeptide CCR5 antagonist with highly
potent and selective anti-HIV-1 activity.  Proc Natl Acad Sci U S
A 1999, 96(10):5698-5703.
37. Breen RA, Swaden L, Ballinger J, Lipman MC: Tuberculosis and HIV
co-infection: a practical therapeutic approach.  Drugs 2006,
66(18):2299-2308.
38. Parodi C, Belmonte L, Bare P, de Bracco MM, Ruibal-Ares B: Impact
of human immune deficiency virus infection on hepatitis C
virus infection and replication.  Curr HIV Res 2007, 5(1):55-67.
39. Salmon-Ceron D, Lewden C, Morlat P, Bevilacqua S, Jougla E, Bonnet
F, Heripret L, Costagliola D, May T, Chene G: Liver disease as a
major cause of death among HIV infected patients: role of
hepatitis C and B viruses and alcohol.  J Hepatol 2005,
42(6):799-805.
40. Lingappa JR, Celum C: Clinical and therapeutic issues for herpes
simplex virus-2 and HIV co-infection.  Drugs 2007,
67(2):155-174.
41. Schwarcz SK, Kellogg TA, McFarland W, Louie B, Klausner J, Withum
DG, Katz MH: Characterization of sexually transmitted dis-
ease clinic patients with recent human immunodeficiency
virus infection.  J Infect Dis 2002, 186(7):1019-1022.
42. Mbopi-Keou FX, Belec L, Teo CG, Scully C, Porter SR: Synergism
between HIV and other viruses in the mouth.  Lancet Infect Dis
2002, 2(7):416-424.
43. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA: Expression
of the peptide antibiotic human beta-defensin 1 in cultured
gingival epithelial cells and gingival tissue.  Infect Immun 1998,
66(9):4222-4228.
44. Abu-Raddad LJ, Patnaik P, Kublin JG: Dual infection with HIV and
malaria fuels the spread of both diseases in sub-Saharan
Africa.  Science 2006, 314(5805):1603-1606.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Retrovirology 2008, 5:29 http://www.retrovirology.com/content/5/1/29
Page 14 of 14
(page number not for citation purposes)
45. Idemyor V: Human immunodeficiency virus (HIV) and malaria
interaction in sub-Saharan Africa: the collision of two Titans.
HIV Clin Trials 2007, 8(4):246-253.
46. Guenthner PC, Secor WE, Dezzutti CS: Trichomonas vaginalis-
induced epithelial monolayer disruption and human immun-
odeficiency virus type 1 (HIV-1) replication: implications for
the sexual transmission of HIV-1.  Infect Immun 2005,
73(7):4155-4160.
47. Nonnenmacher C, Dalpke A, Rochon J, Flores-de-Jacoby L, Mutters
R, Heeg K: Real-time polymerase chain reaction for detection
and quantification of bacteria in periodontal patients.  J Perio-
dontol 2005, 76(9):1542-1549.
48. Bodet C, Chandad F, Grenier D: Modulation of cytokine produc-
tion by Porphyromonas gingivalis in a macrophage and epi-
thelial cell co-culture model.  Microbes Infect 2005, 7(3):448-456.
49. Qi X, Koya Y, Saitoh T, Saitoh Y, Shimizu S, Ohba K, Yamamoto N,
Yamaoka S, Yamamoto N: Efficient induction of HIV-1 replica-
tion in latently infected cells through contact with CD4(+) T
cells: Involvement of NF-kappaB activation.  Virology 2007,
361(2):325-334.
50. Allam JP, Novak N, Fuchs C, Asen S, Berge S, Appel T, Geiger E,
Kochan JP, Bieber T: Characterization of dendritic cells from
human oral mucosa: a new Langerhans' cell type with high
constitutive FcepsilonRI expression.  J Allergy Clin Immunol 2003,
112(1):141-148.
51. Hasseus B, Jontell M, Bergenholtz G, Dahlgren UI: Langerhans cells
from human oral epithelium are more effective at stimulat-
ing allogeneic T cells in vitro than Langerhans cells from
skin.  Clin Exp Immunol 2004, 136(3):483-489.
52. Saphire AC, Bobardt MD, Gallay PA: Cyclophilin a plays distinct
roles in human immunodeficiency virus type 1 entry and
postentry events, as revealed by spinoculation.  J Virol 2002,
76(9):4671-4677.
53. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven
GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman
DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific
HIV-1-binding protein that enhances trans-infection of T
cells.  Cell 2000, 100(5):587-597.
54. Xie H, Belogortseva NI, Wu J, Lai WH, Chen CH: Inhibition of
human immunodeficiency virus type 1 entry by a binding
domain of Porphyromonas gingivalis gingipain.  Antimicrob
Agents Chemother 2006, 50(9):3070-3074.
55. Daecke J, Fackler OT, Dittmar MT, Krausslich HG: Involvement of
clathrin-mediated endocytosis in human immunodeficiency
virus type 1 entry.  J Virol 2005, 79(3):1581-1594.
56. Marechal V, Clavel F, Heard JM, Schwartz O: Cytosolic Gag p24 as
an index of productive entry of human immunodeficiency
virus type 1.  J Virol 1998, 72(3):2208-2212.
57. Marechal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O:
Human immunodeficiency virus type 1 entry into macro-
phages mediated by macropinocytosis.  J Virol 2001,
75(22):11166-11177.
58. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC,
Adema GJ, van Kooyk Y, Figdor CG: Identification of DC-SIGN,
a novel dendritic cell-specific ICAM-3 receptor that supports
primary immune responses.  Cell 2000, 100(5):575-585.
59. Turville SG, Santos JJ, Frank I, Cameron PU, Wilkinson J, Miranda-Sak-
sena M, Dable J, Stossel H, Romani N, Piatak M Jr., Lifson JD, Pope M,
Cunningham AL: Immunodeficiency virus uptake, turnover,
and 2-phase transfer in human dendritic cells.  Blood 2004,
103(6):2170-2179.
60. Marsh PD: Dental plaque: biological significance of a biofilm
and community life-style.  J Clin Periodontol 2005, 32 Suppl
6:7-15.
61. Lei J, Wu C, Wang X, Wang H: p38 MAPK-dependent and YY1-
mediated chemokine receptors CCR5 and CXCR4 up-regu-
lation in U937 cell line infected by Mycobacterium tubercu-
losis or Actinobacillus actinomycetemcomitans.  Biochem
Biophys Res Commun 2005, 329(2):610-615.
62. Fichorova RN, Tucker LD, Anderson DJ: The molecular basis of
nonoxynol-9-induced vaginal inflammation and its possible
relevance to human immunodeficiency virus type 1 trans-
mission.  J Infect Dis 2001, 184(4):418-428.
63. Decrion AZ, Dichamp I, Varin A, Herbein G: HIV and inflamma-
tion.  Curr HIV Res 2005, 3(3):243-259.
64. Bafica A, Scanga CA, Schito M, Chaussabel D, Sher A: Influence of
coinfecting pathogens on HIV expression: evidence for a role
of Toll-like receptors.  J Immunol 2004, 172(12):7229-7234.
65. Equils O, Faure E, Thomas L, Bulut Y, Trushin S, Arditi M: Bacterial
lipopolysaccharide  activates HIV long terminal repeat
through Toll-like receptor 4.  J Immunol 2001, 166(4):2342-2347.
66. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA,
Louis DN, Li FP, Rheinwald JG: Human keratinocytes that
express hTERT and also bypass a p16(INK4a)-enforced
mechanism that limits life span become immortal yet retain
normal growth and differentiation characteristics.  Mol Cell
Biol 2000, 20(4):1436-1447.
67. Oda D, Watson E: Human oral epithelial cell culture I.
Improved conditions for reproducible culture in serum-free
medium.  In Vitro Cell Dev Biol 1990, 26(6):589-595.
68. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu
X, Shaw GM, Kappes JC: Emergence of resistant human immu-
nodeficiency virus type 1 in patients receiving fusion inhibi-
tor (T-20) monotherapy.  Antimicrob Agents Chemother 2002,
46(6):1896-1905.
69. Popovic M, Read-Connole E, Gallo RC: T4 positive human neo-
plastic cell lines susceptible to and permissive for HTLV-III.
Lancet 1984, 2(8417-18):1472-1473.
70. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popo-
vic M: The role of mononuclear phagocytes in HTLV-III/LAV
infection.  Science 1986, 233(4760):215-219.
71. Reed LJ Muench, H.: A simple method of estimating fifty per
cent endpoint.  Am J Hyg 1938, 27:493-497.
72. Biacchesi S, Skiadopoulos MH, Yang L, Murphy BR, Collins PL, Buch-
holz UJ: Rapid human metapneumovirus microneutralization
assay based on green fluorescent protein expression.  J Virol
Methods 2005, 128(1-2):192-197.
73. Gilchrist JE, Campbell JE, Donnelly CB, Peeler JT, Delaney JM: Spiral
plate method for bacterial determination.  Appl Microbiol 1973,
25(2):244-252.
74. Livak KJ, Schmittgen TD: Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method.  Methods 2001, 25(4):402-408.